Zantac Investor Class Action Time-Barred, Pa. Judge Rules
The maker of heartburn and acid reflux relief tablet Zantac has defeated a securities fraud class action claiming the company hid for decades the cancer risks associated with the drug, causing...To view the full article, register now.
Already a subscriber? Click here to view full article